Melissa Deri


Assistant Professor



Department of Chemistry


Lehman College CUNY


250 Bedford Park Blvd West
Bronx, NY 10468



Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO.


Journal article


N. Bhupathiraju, A. Younes, Minhua Cao, J. Ali, Huseyin T. Cicek, K. Tully, S. Ponnala, J. Babich, M. Deri, Jason S. Lewis, L. Francesconi, C. M. Drain
Organic & biomolecular chemistry, 2019

Semantic Scholar DOI PubMed
Cite

Cite

APA
Bhupathiraju, N., Younes, A., Cao, M., Ali, J., Cicek, H. T., Tully, K., … Drain, C. M. (2019). Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO. Organic & Biomolecular Chemistry.

Chicago/Turabian
Bhupathiraju, N., A. Younes, Minhua Cao, J. Ali, Huseyin T. Cicek, K. Tully, S. Ponnala, et al. “Improved Synthesis of the Bifunctional Chelator p-SCN-Bn-HOPO.” Organic & biomolecular chemistry (2019).

MLA
Bhupathiraju, N., et al. “Improved Synthesis of the Bifunctional Chelator p-SCN-Bn-HOPO.” Organic & Biomolecular Chemistry, 2019.


Abstract

The bifunctional ligand p-SCN-Bn-HOPO, which has four 1,2-hydroxypyridinone groups on a spermine backbone with an isothiocyanate linker, has been shown to be an efficient and stable chelator for Zr(iv) and, more importantly, the radioisotope 89Zr for use in radiolabeling antibodies for positron emission tomography (PET) imaging. Previous studies of 89Zr-HOPO-trastuzumab in mice showed low background, good tumor to organ contrast, and very low bone uptake which show p-SCN-Bn-HOPO to be an important next-generation bifunctional chelator for radioimmunoPET imaging with 89Zr. However, the reported synthesis of p-SCN-Bn-HOPO involves nine steps and multiple HPLC purifications with an overall yield of about 1.4%. Herein we report an improved and efficient synthesis of p-SCN-Bn-HOPO in four steps with 14.3% overall yield which will improve its availability for further biological studies and wider application in PET imaging. The new synthetic route also allows variation in linker length and chemistries which may be helpful in modifying in vivo clearance behaviors of future agents.


Share